Terence Flynn Analyst Performance

Equity Research Analyst at Morgan Stanley

Terence Flynn is a stock analyst at Morgan Stanley focused in the medical sector, covering 25 publicly traded companies. Over the past year, Terence Flynn has issued 39 stock ratings, including buy, hold, and sell recommendations. While full access to Terence Flynn's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Terence Flynn's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

56 Last 10 Years

Buy Recommendations

41.51% 22 Buy Ratings

Companies Covered

25 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	1.9%	1 ratings
Buy	39.6%	21 ratings
Hold	54.7%	29 ratings
Sell	3.8%	2 ratings

Out of 53 total stock ratings issued by Terence Flynn at Morgan Stanley, the majority (54.7%) have been Hold recommendations, followed by 39.6% Buy, 3.8% Sell, and 1.9% Strong Buy.

Best & Worst Calls

• Best Call

  000.0%

  AMGN

  Sep 2019

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  CLVS

  May 2015

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	60.0% of companies on NASDAQ	15 companies
NYSE	40.0% of companies on NYSE	10 companies

Terence Flynn, an analyst at Morgan Stanley, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 24 companies	96.0%
	Miscellaneous 1 company	4.0%

Terence Flynn of Morgan Stanley specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 14 companies	56.0%
LARGE CAP PHARMA 5 companies	20.0%
PHARMACEUTICAL PREPARATIONS 2 companies	8.0%
MED - DRUGS 1 company	4.0%
MEDICAL SERVICES 1 company	4.0%
HOSPITAL & MEDICAL SERVICE PLANS 1 company	4.0%
Miscellaneous 1 company	4.0%

About Terence Flynn

Terence C. Flynn currently works at Morgan Stanley & Co. LLC, as Equity Analyst from 2021. Dr. Flynn also formerly worked at Cytec Industries, Inc., as Research Laboratory Technician, Needham & Co. LLC, as Analyst, Goldman Sachs & Co. LLC, as Analyst from 2010 to 2021, and FM Partners Holdings LLC, as Research Analyst from 2004 to 2009. Dr. Flynn received his doctorate degree from William Marsh Rice University and undergraduate degree from Cornell University.

Follow on LinkedIn

Terence Flynn's Ratings History at Morgan Stanley

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
ALMS Alumis	8/15/2025	Lower Price Target	$4.39	$22.00	Overweight	$0.00 00.00% ROI
BHVN Biohaven	8/12/2025	Lower Price Target	$13.42	$54.00	Overweight	$0.00 00.00% ROI
PFE Pfizer	8/6/2025	Boost Price Target	$23.96	$33.00	Equal Weight	$0.00 00.00% ROI
AMGN Amgen	8/6/2025	Boost Price Target	$284.41	$333.00	Equal Weight	$0.00 00.00% ROI
ABBV AbbVie	8/1/2025	Boost Price Target	$193.55	$255.00	Overweight	$0.00 00.00% ROI
BMY Bristol Myers Squibb	7/31/2025	Reiterated Rating	$43.37		Hold	$0.00 00.00% ROI
JNJ Johnson & Johnson	7/17/2025	Boost Price Target	$164.78	$176.00	Equal Weight	$0.00 00.00% ROI
NRIX Nurix Therapeutics	7/15/2025	Set Price Target	$12.69	$16.00	Equal Weight	$0.00 00.00% ROI
RPRX Royalty Pharma	7/10/2025	Boost Price Target	$36.18	$54.00	Overweight	$0.00 00.00% ROI
BNTX BioNTech	7/10/2025	Boost Price Target	$112.29	$133.00	Overweight	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
LLY Eli Lilly and Company	7/10/2025	Reiterated Rating	$792.63	$1,135.00	Overweight	$0.00 00.00% ROI
MRK Merck & Co., Inc.	7/10/2025	Lower Price Target	$84.40	$98.00	Equal Weight	$0.00 00.00% ROI
JNJ Johnson & Johnson	7/10/2025	Boost Price Target	$157.81	$171.00	Equal Weight	$0.00 00.00% ROI
BMY Bristol Myers Squibb	7/10/2025	Lower Price Target	$48.17	$34.00	Underweight	$0.00 00.00% ROI
UTHR United Therapeutics	7/10/2025	Lower Price Target	$301.15	$328.00	Equal Weight	$0.00 00.00% ROI
ARVN Arvinas	5/9/2025	Lower Price Target	$6.69	$11.00	Equal Weight	$0.00 00.00% ROI
RCUS Arcus Biosciences	5/9/2025	Lower Price Target	$8.46	$22.00	Overweight	$0.00 00.00% ROI
BNTX BioNTech	5/6/2025	Lower Price Target	$99.33	$132.00	Overweight	$0.00 00.00% ROI
OGN Organon & Co.	5/5/2025	Lower Price Target	$8.82	$10.00	Equal Weight	$0.00 00.00% ROI
UTHR United Therapeutics	5/1/2025	Boost Price Target	$296.52	$348.00	Equal Weight	$0.00 00.00% ROI
ABBV AbbVie	4/28/2025	Boost Price Target	$185.96	$250.00	Overweight	$0.00 00.00% ROI
JNJ Johnson & Johnson	4/16/2025	Boost Price Target	$154.80	$169.00	Equal Weight	$0.00 00.00% ROI
OGN Organon & Co.	4/9/2025	Lower Price Target	$11.32	$15.00	Equal Weight	$0.00 00.00% ROI
LLY Eli Lilly and Company	4/9/2025	Lower Price Target	$702.91	$1,124.00	Overweight	$0.00 00.00% ROI
JNJ Johnson & Johnson	4/9/2025	Boost Price Target	$146.25	$164.00	Equal Weight	$0.00 00.00% ROI
ABBV AbbVie	4/9/2025	Boost Price Target	$167.66	$241.00	Overweight	$0.00 00.00% ROI
AMGN Amgen	4/9/2025	Boost Price Target	$272.28	$330.00	Equal Weight	$0.00 00.00% ROI
ARVN Arvinas	3/13/2025	Lower Price Target	$8.58	$12.00	Equal Weight	$0.00 00.00% ROI
BNTX BioNTech	3/11/2025	Lower Price Target	$100.97	$139.00	Overweight	$0.00 00.00% ROI
BHVN Biohaven	3/7/2025	Lower Price Target	$30.08	$63.00	Overweight	$0.00 00.00% ROI
RCUS Arcus Biosciences	2/18/2025	Lower Price Target	$11.00	$25.00	Overweight	$0.00 00.00% ROI
CRSP CRISPR Therapeutics	2/14/2025	Boost Price Target	$43.49	$32.00	Underweight	$0.00 00.00% ROI
OGN Organon & Co.	2/14/2025	Lower Price Target	$16.17	$16.00	Equal Weight	$0.00 00.00% ROI
MRK Merck & Co., Inc.	2/5/2025	Lower Price Target	$90.99	$106.00	Equal Weight	$0.00 00.00% ROI
NRIX Nurix Therapeutics	2/3/2025	Boost Price Target	$19.71	$17.00	Equal Weight	$0.00 00.00% ROI
ABBV AbbVie	2/3/2025	Boost Price Target	$188.39	$239.00	Overweight	$0.00 00.00% ROI
NTLA Intellia Therapeutics	1/27/2025	Downgrade	$10.99	$11.00	Equal Weight	$0.00 00.00% ROI
JNJ Johnson & Johnson	1/23/2025	Lower Price Target	$146.82	$163.00	Equal Weight	$0.00 00.00% ROI
MRK Merck & Co., Inc.	1/21/2025	Lower Price Target	$96.46	$113.00	Equal Weight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.